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Collecting duct cell carcinomaWereport an anti-SV40positive collectingduct (CD) cell carcinoma in a renal allograft 4.5 years after transplantation
that developed during smoldering BK virus (BKV) nephropathy. In the allograft biopsy six months after transplan-
tation documenting BK nephropathy, anti-SV40 positivity co-localized with the CDmarker CK-HMWand prolifera-
tion marker MIB-1, suggesting that BKV preferentially infects CD cells and causes them to proliferate. In previous
reports on BKV related renal malignancies, immunohistochemistry also pointed to a CD origin of the tumors. Six ad-
ditional cases of BKV induced renal tumors were found in four CD carcinoma case-reports and one large case-series
of “usual” CD carcinomas, supporting the hypothesis that BKV speciﬁcally induce CD cell tumor formation. In viewof
the rarity of BKV induced tumors a second hit might be needed to induce malignancy. In our case the use of
lithium—which also causes CD cell proliferation—at the time of BKV infection may have provided this second hit.
© 2016 Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The BK virus (BKV) is a polyomavirus that causes tubulo-interstitial
nephritis in approximately 5–10%of renal transplant recipients, and this
BK nephropathy is an important cause of graft loss [1]. The BKVmay also
speciﬁcally infect the transitional epithelium of the urinary collecting
system, causing ureteral stenosis and hemorrhagic cystitis [1]. BKV in-
fection has also been associated with the development of malignancies
in the ureter and bladder of transplanted patients [2,3]. In addition, the
association between BKV infection and the development of malignan-
cies in kidneys have been reported [4–19].
We report a kidney transplant recipient with BKV nephropathy six
months after transplantation who presented with a collecting duct (CD)0, cluster of differentiation 10;
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Case Reports (2016), http://cell carcinoma in the allograft four years later, and show that CD cell
proliferation was already present when BKV nephropathy became evi-
dent. In addition, we provide a review of the literature on BKV asso-
ciated renal malignancies and hypothesize that the BKV has a
predilection for infection and malignant transformation of epithelia
embryonically derived from the Wolfﬁan duct, including the bladder,
ureters and the collecting ducts.2. Case
A 62-year-old female with bipolar disease and renal failure due to
lithium nephrotoxicity underwent pre-emptive kidney transplantation.
Because psychiatric deterioration was anticipated in the peri-
transplantation period, lithium was re-introduced three months prior
to transplantation. Immunosuppression consisted of prednisolone,
tacrolimus andmycophenolate. The lowest plasma creatinine concentra-
tionwas 1,1mg/dL threeweeks after transplantation (Fig. 1). Because this
value increased to 1,6mg/dL threemonths after transplantation, a kidney
biopsy was performed that showed no clear abnormalities (Fig. 2A).
Sixmonths after transplantation, the plasma creatinine concentration
increased to 2,1 mg/dL. Two weeks earlier, lithiumwas stopped because
of progressive renal failure. A repeat kidney biopsy showed pronounced
nuclear abnormalities with enlarged nuclei with a ground glass aspect
and peripheral localization of chromatin. There was strong nuclear
staining for SV40 (Calbiochem, anti-SV40 T antigen mouse mAb) and-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Fig. 1. Plasma creatinine concentration (closed dots) and BK viral load (open dots) after renal transplantation (RTX). Arrows indicate renal biopsies in July and October 2006 and January
2007 (respectively 3, 6 and 9 months after RTX). Cidofovir treatment (line) included eight infusions during four months.
2 NMH. Veldhuijzen et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxBKV nephropathy was diagnosed (Fig. 2B). The blood BK viral load was
markedly elevated (6.4e6 copies/mL). Immunosuppressionwas reduced
by stopping mycophenolate, and oral leﬂunomide was started.
Despite this, the plasma creatinine concentration had risen to
2,9 mg/dL nine months after transplantation and the blood BK viral
load remained elevated (11.5e6 copies/mL). A third kidney biopsy was
performed which, in addition to ongoing BKV nephropathy, also
showed an acute cellular vascular rejection (Banff IIa). Interestingly, in
retrospect there was co-localization of immunohistochemical staining
for SV40, CK-HMW and Ki-67 (MIB-1), suggesting a proliferative
response speciﬁcally in CD cells (Fig. 2C). Pulse corticosteroids were
given and intravenous cidofovir treatment was started (eight courses,
1 mg/kg, divided over four months). Immunosuppression consisted of
low-dose tacrolimus and prednisolone. Post aut propter, the plasma
creatinine value stabilized at ~2.8 mg/dL. The blood BK viral load
decreased several log steps, but did not become immeasurable and
stabilized at a level of 1000 copies/mL.
After this, the patient did well until she presented 4.5 years after
transplantation with fatigue, night sweats, fever, and weight loss. A CT
scan showed a solid mass in the upper pole of the kidney transplant. A
biopsy showed adenocarcinoma. Interestingly, all tumor cells stained
strongly positive for SV40. No local or distant tumor masses were
found, and the patient underwent transplantectomy, all immunosup-
pressants were stopped and hemodialysis was started.
On gross examination, the resected graft (9.5 × 7.5 × 4.5 cm)
contained a tumor with a diameter of 5.7 cm, bulging into the pelvis.
Atmicroscopic examination the tumor cells had bizarre, hyperchromatic
nuclei with prominent nucleoli surrounded by moderately abundant
cytoplasm (Fig. 3A). SV-40 stained strongly positive in the nuclei of
tumor cells but not in cells in the surrounding cortex and medulla
(Fig. 3B). The tumor cells were positive for CK5/6, CK-HMW (Fig. 3C),
CK19, PAX-8, CK7, EMA and E-cadherin, weakly positive for p63 and
negative for N-cadherin and GATA-3. Furthermore, the pelvic mucosa
consisted of normally differentiated urothelium and no relation was
seen between the tumor and the pelvic mucosa. These observations
indicate that the tumor had originated in the collecting ducts and not
in the upper tract urothelium. The tumor showed a predominantly
pushing border of invasion with small foci of inﬁltrating tumor nests.
The surgical margins were free of tumor.
Approximately 2.5 years after transplantectomy, the patient
received a second kidney transplant. The present immunosuppressive
regimen consists of prednisolone, mycophenolate and everolimus,Please cite this article as: NMH.Veldhuijzen, et al., BK virus nephropathy, co
history and review of the liter..., Human Path Case Reports (2016), http://and the patient is doing well without BK viremia or tumor recurrence
(follow-up approximately 24 months).
3. Discussion
We present a patient with a CD cell carcinoma in a renal allograft
4.5 years after transplantation and submit that BKV-induced prolifera-
tion of CD cells in the context of ongoing BKV nephropathy contributed
to development of this tumor. This hypothesis is supported by the ob-
servation that the BKV infection was limited to the collecting ducts
(co-localization of anti-SV40 and anti CK-HMW staining) and that
only this nephron segment showed a proliferative response (nuclear
co-staining with the proliferation marker Ki-67).
The oncogenic potential of polyoma viruses, including the BKV, has
long been recognized [18]. In a retrospective study, Bulut et al. showed
that the presence of BKV DNA resulted in a ﬁvefold increase in the risk
of development of renal malignancies [6]. Various “early” T (tumor)
antigens, proteins encoded by the BKV genome, push the cells into the
proliferative G2/S phase to facilitate viral DNA transcription and virus
replication. For example, L-TAg binds and inactivates nuclear tumor
suppressor proteins such as p53 and pRb. [20] Indeed, p53 has been
shown to accumulate in the nuclei of L-TAg positive cells in patients
with BKV nephropathy. [21] Interestingly, many of these cells also
express the proliferation marker Ki-67. [22] Various “late” antigens
contribute to capsid production, virus particle assembly and ultimately
cell lysis leading to virus dissemination. In principle, this cell lysis will
prevent ongoing proliferation and as such is incompatible with tumor
formation. However, uncoupling of early and late gene expression by
viral mutations may produce an oncogenic state by preventing viral
assembly and host cell lysis [2]. Especially protracted infections with
ongoing virus replication increase the chance of accumulating muta-
tions and may predispose to tumor development [2].
In addition to the present case, several others have been reporting
on the association between BKV nephropathy and renal malignancy.
Although several reports describe urothelial cell carcinomas in the
(allograft) kidney, [12–17] eight studies report renal malignancies that
are comparable to our case (Table 1) [4–11]. In four cases and in our
patient, the resultswere considered compatiblewith a CD cell carcinoma.
[9–11] Emerson et al. [9] reported a patient with ongoing BKV ne-
phropathy and viremia in whom a renal allograft CD carcinoma was
found 3.5 years after transplantation. A relation between tumor develop-
ment and BKV infectionwas suggested by nuclear staining of tumor cellsllecting duct cell proliferation andmalignancy in a renal allograft: Case
dx.doi.org/10.1016/j.ehpc.2016.10.003
Fig. 2. BK nephropathy after renal transplantation. A: a renal biopsy taken at 3 months after transplantation shows no obvious changes in the PAS stain (upper panel), but faint positive
immunohistochemical non-speciﬁc cytoplasmic staining for SV40 (BKV LTag) in some tubular cells (lower panel). B: a biopsy at 6months after transplantation shows clear viral cytopathic
effects in the PAS stain (upper panel) and prominent nuclear staining for SV40 (lower panel), consistent with BK nephropathy. C: a renal biopsy at 9 months after transplantation shows
extensive BK nephropathy. There is co-localization of positive tubular segments for SV40, CK-HMW, and MIB-1.
3NMH. Veldhuijzen et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxwith an antibody directed against L-TAg, although in situ hybridization
for BKV in the tumor was negative. In addition, two cases of BKV associ-
ated malignancies in renal allografts with a similar immunohistochemi-
cal proﬁle were reported in a recent large case series of CD cell
carcinomas [11]. Finally, the observation that a SV-40 positive CD cell
carcinoma associated with BKV nephropathy was recently reported in
the native kidney of a pulmonary allograft recipient [10] lends further
support to the notion that the BKV might speciﬁcally induce CD
cell carcinomas.
Narayanan et al. [5] reported a poorly differentiated renal allograft
carcinoma with para-aortic lymph node metastasis ﬁve years after
combined kidney-pancreas transplantation. Three years earlier, BKV
nephropathy had been diagnosed. A robust causal relation between
tumor development and BKV infectionwas suggested by immunohisto-
chemical staining of tumor cell nuclei for the L-TAg (anti-SV40 anti-
body), and by the detection of viral DNA by in situ hybridization and
PCR in the tumor. Neirynck et al. [6] reported a case of a renal cellPlease cite this article as: NMH.Veldhuijzen, et al., BK virus nephropathy, co
history and review of the liter..., Human Path Case Reports (2016), http://carcinoma in a kidney transplant displaying anti-L-TAg staining in the
urothelium, non-neoplastic renal tissue and the tumor. Retrospectively,
anti-L-TAg stainingwas present in a biopsy taken because of a nephrotic
syndrome two years earlier that showed no histopathological signs
of BKV nephropathy. Unfortunately no speciﬁc interpretation of the
immunohistochemistry results was given in these last two papers, but
the staining proﬁle was suggestive for a distal nephron origin of the
tumors (Table 2) [23,24]. It is of note that in some reports the described
immunohistochemical proﬁle of the tumors does not allow adequate
determination of its origin but to do not exclude the possibility that
these tumors are also CD derived [4,7,8,25]. The association in these
reports between BK infection and the relative rare tumor of the
collecting duct suggesting a causal relation between tumor develop-
ment and BKV infection was supported by speciﬁc viral cytopatic
changes [11], by immunohistochemical staining of tumor cell nuclei
for the L-TAg (anti-SV40 antibody) [5,6,9,10], by the detection of viral
DNA by in situ hybridization [5] and PCR in the tumor [5,7].llecting duct cell proliferation andmalignancy in a renal allograft: Case
dx.doi.org/10.1016/j.ehpc.2016.10.003
Fig. 3. Collecting duct carcinoma in renal allograft. A: tumor cells have bizarre,
hyperchromatic nuclei and clear nucleoli, surrounded by clear cytoplasm (H&E stain).
B: all tumor cells show strong nuclear positivity for SV40. C: all tumor cells are positive
for CK-HMW.
4 NMH. Veldhuijzen et al. / Human Pathology: Case Reports xxx (2016) xxx–xxxInterestingly, the CD also appears to be the site of maximal tubular
damage in BKV nephropathy [26–28]. Because BKV infection and asso-
ciated malignancies also occur in the ureter, pelvis, and bladder, the virus
seems to have a preference for epithelia derived from the mesodermal
Wolfﬁan ducts. The BKV has been suggested to hibernate in the kidneys
after primo-infection [29], and the observations presented above suggest
that Wolfﬁan duct derived epithelia may be the preferred site.
Serological evidence indicates that the prevalence of BKV infection
in the general population is as high as 85%. Considering that the inci-
dence of BKV allograft nephropathy due to reactivation of the virus is
5–10% [1], the incidence of tumor development in renal allografts in
association with BKV nephropathy appears to be extremely low as up
till now only seven cases have been reported [4–6,8,9,11]. Because of
the generally long interval between transplantation and tumor develop-
ment, it has been suggested that the risk for neoplasms after BKV infec-
tionmaywell bemultifactorial [19]. Additional hitsmight be needed for
BKV to induce tumor formation. In our patient, lithium exposure at the
time of BKV reactivation may have been such an additional hit, as
lithium has been shown to induce CD cell proliferation and CD tumor
formation [30].Please cite this article as: NMH.Veldhuijzen, et al., BK virus nephropathy, co
history and review of the liter..., Human Path Case Reports (2016), http://Although CD carcinomas are a very malignant tumors with a poor
prognosis [11], BKV relatedCD carcinomas, seem tohave amore favorable
prognosis. In our patient and in one published case, [9] there was no
metastatic disease at the time of diagnosis and no recurrence during
follow-up up to three years. In one case, lymph node and pulmonary [6]
metastases were documented, but they regressed after transplantectomy
and withdrawal of immunosuppression (follow-up two years). Finally, a
recipient of a pancreas-kidney transplantation, who presented with a
para-aortic lymph node metastasis two months after removal of the
renal allograft, fared well after lymph node excision. He was switched to
sirolimus and low-dose prednisone and had no recurrent disease and
good pancreatic allograft function for 15 months while on hemodialysis
[5]. Only one report of BK associated CD tumor reported an unfavorable
outcome [10]. Interestingly, Kausman et al. [4], reported a patient who
developed a poorly differentiated carcinoma of the allograft after BKV
nephropathy,with regional lymphnodemetastases at diagnosis. Removal
of the primary tumor and cessation of immunosuppression led to regres-
sion of secondary tumors and a return to health. The other studies unfor-
tunately do not provide data on clinical outcome [7,8,11].
In summary, we present a case of a CD cell carcinoma developing in
the context of non-resolving BK allograft nephropathy. A review of the
literature suggests that previously reported cases of BKV-associated
allograft carcinomas were also of CD origin. Because BKV related allo-
graft tumors are rare and BKV reactivation after renal transplantation
is common, additional hits seem to be necessary to induce tumor forma-
tion. In our patient, lithium exposure at the time of BKV reactivation
may have provided such a second hit. Although the prognosis of the
classical CD cell carcinoma is poor, that of the BKV associated variant
appears to be more favorable, provided that the allograft is removed
and immunosuppressive drugs are stopped.References
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Table 1
BKV associated renal tumors in the literature.
n Sex Type of Tx Age
at Tx
BKV
nephropathy
BKV
veriﬁcation
in biopsy
Tumor
diagnosis
post-transplant
Histology BKV in tumor BKV non-tumor
tissue
Kausman
(ref. [4])
1 M Kidney 11.8 yr 10 monthsa ISH
positive
3.8 yr Undifferentiated
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anti-SV40 NR
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Naranyan
(ref. [5])
1 M Kidney/pancreas 40 yr 26 monthsb ISH positive
anti-SV40
positive
PCR
positive
5.3 yr Undifferentiated
carcinoma
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anti-SV40 positive
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1 F Kidney 52 yr No Anti-SV40
positivec
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Dufek
(ref. [10])
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Gupta
(ref.
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2 1M/1F Kidney NR NR Yes NR CDC Viral cytopatic changes Viral cytopatic
changes
Current study F Kidney 62 yr 6 monthsn Anti-SV40
positiveo
4.5 yr CDC Anti SV40 positive Anti SV40 negative
Abbreviations: BKV = BK virus; Tx = transplantation; ISH = in situ hybridization; NR = not reported; PCR = polymerase chain reaction; RCC: renal cell carcinoma; CDC: collecting
duct carcinoma; TCC: transitional cell carcinoma.
a Urine viral culture and PCR BKV positive.
b Urine and serum PCR BKV positive.
c Biopsy 5 years after NTX in retrospect showed anti-SV40 positivity in normal tubules.
d Both nuclear and cytoplasmic staining.
e Anti-SV40 positive in urothelium and non-tumor renal parenchyma.
f 50 cancer patients with RCC. Not reported if and how many of analyzed renal tissues concerned allograft kidneys or if patients have been transplanted at all.
g Analysis in 45 control patients with benign renal pathology.
h 6 patients with polyomavirus-associated nephropathy (5 BKV, 1 JC virus) after renal transplantation. Malignancy occurred in 5 patients: 1 RCC, 4 other malignancies (2 TCC in the
bladder, 1 squamous cell carcinoma in the skin, 1 Kaposi sarcoma of the leg), 4.0 ± 2.5 years after transplantation.
i Anti-SV40 positive in transplant biopsies 6, 26 and 33 months after NTX.
j Elective transplantectomy for transplant failure, tumor not diagnosed prior to transplantectomy.
k Urothelium and tubules.
l Native kidneys.
m 39 cases of CDC and 13 cases of renal medullary carcinoma. Clinicopathologic and immunohistochemical features were evaluated to determine their interrelationship. Two cases of
CDC were noted in failed allograft renal transplants. One of these, a 10-year-old boy, demonstrated BKV nephropathy, and a 41-year-old woman had latent BKV infection.
n Serum PCR BKV positive.
o High blood and urine BK viral load by PCR.
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Immunohistochemistry proﬁles in four BK virus-induced tumors.
Narayanan (ref. [5]) Neirynck
(ref. [6])
Emerson
(ref. [9])
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CK19 nd Positive Positive Positive
CK5/6 nd nd Positive Positive
CK20 Negative nd Negative Negative
CKHMW nd nd nd Positive
Vimentin Positive nd Positive Positive
E-cadherin nd nd nd Positive
N-cadherin nd nd nd Negative
Anti-SV40 Positive Positive Positive Positive
Abbreviations: CK: cytokeratin; HMW: high molecular weight; nd: not done.
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